Brian Tanquilut

Jefferies | Healthcare

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector. Ranked #2162 out of 4733 analysts, they have issued 21 stock ratings with a success rate of 79.60% and an average return of 17.17%.

Brian Tanquilut has a well-established track record, with 21 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 79.60% and an average return of 17.17%, underscoring their expertise and ability to identify winning opportunities for investors.

#2162

Out of 4733

21

Total Ratings

+79.60%

Success Rate

+17.17%

Average Return

Recent Ratings Analysis

AHCO

Jul 21, 2026

Target

$13.00

Current

$11.21

Performance

0.00%

Brian Tanquilut rated AHCO as Buy on Jul 21, 2026, setting a price target of 13. Shares have remained stable near 11.21, leaving the 13 target still in play.

ACHC

Jun 03, 2026

Target

$30.00

Current

$35.61

Performance

38.40%

On Jun 03, 2026, ACHC was given a Buy rating by Brian Tanquilut, with a target price of 30. The stock rallied 38.40% after the rating, narrowing the gap to the target of 30 and validating the bullish stance.

DOCS

May 14, 2026

Target

$19.00

Current

$21.11

Performance

17.21%

DOCS received a Hold rating from Brian Tanquilut on May 14, 2026, aiming for 19. Investors saw gains of 17.21% that the cautious stance didn’t fully capture.

GRDN

Mar 30, 2026

Target

$44.00

Current

$40.91

Performance

9.83%

On Mar 30, 2026, Brian Tanquilut published a Buy outlook on GRDN, with a target of 44. Shares gained 9.83%, underscoring the accuracy of the bullish outlook toward 44.

USPH

Mar 10, 2026

Target

$102.00

Current

$74.74

Performance

-6.56%

Brian Tanquilut on Mar 10, 2026 assigned USPH a Buy rating, with a price target of 102. The call has struggled to gain traction, with shares losing 6.56%.

ODD

Feb 25, 2026

Target

$64.00

Current

$16.22

Performance

10.04%

On Feb 25, 2026, Brian Tanquilut reaffirmed ODD with a Hold rating, targeting 64. Market strength beyond 16.22 went further than the conservative outlook suggested.

EHAB

Feb 23, 2026

Target

$13.80

Current

$13.80

Performance

1.47%

EHAB was rated Hold by Brian Tanquilut on Feb 23, 2026, with a price objective of 13.8. Flat performance suggests the Hold view was reasonable.

THC

Feb 12, 2026

Target

$265.00

Current

$196.49

Performance

-15.40%

On Feb 12, 2026, Brian Tanquilut initiated coverage on THC with a Buy rating and target of 265. The Buy call has yet to be validated as shares remain 68.51 away from the target.

HCA

Jan 28, 2026

Target

$590.00

Current

$373.09

Performance

-24.05%

Brian Tanquilut issued a Buy recommendation for HCA on Jan 28, 2026, price target set at 590. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

COR

Jan 22, 2026

Target

$440.00

Current

$303.07

Performance

-14.02%

On Jan 22, 2026, COR was evaluated by Brian Tanquilut, who gave a Buy rating and target of 440. Investors saw limited payoff as shares fell short of the 440 target.

CHE

Jan 22, 2026

Target

$475.00

Current

$504.10

Performance

13.35%

Brian Tanquilut rated CHE as Hold on Jan 22, 2026, setting a price target of 475. Despite the Hold call, shares climbed 13.35% to 504.1, revealing unexpected momentum.

LMRI

Jan 05, 2026

Target

$23.00

Current

$11.13

Performance

-33.87%

On Jan 05, 2026, LMRI was given a Buy rating by Brian Tanquilut, with a target price of 23. Despite the Buy call, shares fell from 11.13 to 11.13, challenging the optimistic stance.

AVAH

Oct 28, 2025

Target

$12.50

Current

$9.74

Performance

-0.71%

AVAH received a Buy rating from Brian Tanquilut on Oct 28, 2025, aiming for 12.5. Price action was muted, as shares hovered around 9.74 despite the bullish outlook.

PNTG

Oct 24, 2025

Target

$30.00

Current

$41.47

Performance

64.30%

On Oct 24, 2025, Brian Tanquilut published a Buy outlook on PNTG, with a target of 30. Shares gained 64.30%, underscoring the accuracy of the bullish outlook toward 30.

MCK

Oct 14, 2025

Target

$900.00

Current

$828.84

Performance

6.00%

Brian Tanquilut on Oct 14, 2025 assigned MCK a Buy rating, with a price target of 900. The Buy call aligned well with market performance, producing a gain of 6.00%.

CYH

Jul 24, 2025

Target

$3.00

Current

$3.21

Performance

10.69%

On Jul 24, 2025, Brian Tanquilut reaffirmed CYH with a Hold rating, targeting 3. Market strength beyond 3.21 went further than the conservative outlook suggested.

CVS

Jun 30, 2025

Target

$80.00

Current

$110.60

Performance

60.34%

CVS was rated Buy by Brian Tanquilut on Jun 30, 2025, with a price objective of 80. A bullish response from the market helped close the gap of -30.60 to the target.

CAH

Feb 05, 2025

Target

$150.00

Current

$227.09

Performance

78.18%

On Feb 05, 2025, Brian Tanquilut initiated coverage on CAH with a Buy rating and target of 150. The stock’s climb of 78.18% since the call highlights the foresight in the rating.

OPCH

Jan 23, 2025

Target

$35.00

Current

$21.67

Performance

-27.77%

Brian Tanquilut issued a Buy recommendation for OPCH on Jan 23, 2025, price target set at 35. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

RDNT

Jan 15, 2025

Target

$80.00

Current

$61.87

Performance

0.21%

On Jan 15, 2025, RDNT was evaluated by Brian Tanquilut, who gave a Buy rating and target of 80. So far, the Buy call awaits clearer momentum, with shares flat at 61.87.

LH

Dec 10, 2024

Target

$275.00

Current

$279.40

Performance

19.13%

Brian Tanquilut rated LH as Buy on Dec 10, 2024, setting a price target of 275. The call has proven timely, with shares rising 19.13% toward the price target of 275.

BKD

Oct 16, 2024

Target

$8.00

Current

$15.19

Performance

127.40%

On Oct 16, 2024, BKD was given a Buy rating by Brian Tanquilut, with a target price of 8. The stock rallied 127.40% after the rating, narrowing the gap to the target of 8 and validating the bullish stance.

MODV

Sep 13, 2024

Target

$14.00

Current

$0.43

Performance

-96.94%

MODV received a Hold rating from Brian Tanquilut on Sep 13, 2024, aiming for 14. The Hold stance proved prudent, with the market softening by 96.94%.

Frequency Asked Questions

Who is Brian Tanquilut?

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector.

What is Brian Tanquilut's success rate?

Brian Tanquilut currently has a success rate of +79.60%.

How many ratings has Brian Tanquilut issued?

Brian Tanquilut has issued 21 stock ratings so far.

What is the average return of Brian Tanquilut's calls?

Their stock ratings have generated an average return of +17.17%.

What is Brian Tanquilut's ranking?

Brian Tanquilut is ranked #2162 out of 4733 analysts.

What types of ratings does Brian Tanquilut give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Brian Tanquilut?

You can follow Brian Tanquilut by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Brian Tanquilut?

Their latest rating was a Buy on AHCO issued on 2026-07-21.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep